AngioDynamics Cardiovascular
@AngioDynamicsCV
We believe advancing care starts with trusting and investing in those who provide it. Risk Information: https://bit.ly/3UFe4Rf
Może Ci się spodobać
#AMBITIONBTK continues to expand! Congratulations to Dr. Sayfo and his team at Baylor Scott & White Health on enrolling their first patient. We’re thankful for their efforts! bit.ly/464ZJTE Risk: bit.ly/3UFe4Rf *Dr. Sayfo is a paid consultant of AngioDynamics
In the coming weeks, we will launch our new AngioDynamics Cardiovascular profile built to enhance engagement with our partners, fostering stronger collaborations and better solutions for patients.▶️ bit.ly/3IQ52yI Risk Info▶️ bit.ly/3UFe4Rf #CardiovascularCare
Congratulations to Dr. Matt Finn and the team at @CardioInstitute for enrolling their first patient in #AMBITIONBTK! Learn more▶️ bit.ly/464ZJTE Risk information▶️ bit.ly/3UFe4Rf #AngioDynamics #Auryon #TheAuryonSystem
It’s exciting to see new sites join #AMBITIONBTK – congratulations to Dr. Guevara and the team at Barnes Jewish Hospital on their first patient enrollment! Learn more> bit.ly/464ZJTE Risk information> bit.ly/3UFe4Rf #AngioDynamics #TheAuryonSystem #AMBITIONBTK
We’re excited to announce that Dr. Sameh Sayfo from @bswhealth will be presenting at the Peripheral Vascular Trainee Lab (PVTL) in Chicago on October 11. The Auryon System ▶️ bit.ly/47aRiYV #PAD #AuryonSystem #PVTL Risk Info: bit.ly/3IOQLC2
✔️94% freedom from TLR at 12 months ✔️Significant improvements in Rutherford-Becker category and quality of life (EQ-5D) ✔️Minimal need for bailout stenting – just 1.6% of lesions bit.ly/46oVX7t #AuryonLaser #EndovascularTherapy #CLTI #PAD Risk: bit.ly/3IOQLC2
In honor of PAD Awareness Month, AngioDynamics is proud to announce successful continued enrollment of the AMBITION BTK randomized controlled trial. ▶️ bit.ly/464ZJTE Risk information ▶️ bit.ly/3UFe4Rf The AMBITION BTK study is sponsored by AngioDynamics.
This PAD Awareness Month, we’re proud to celebrate five years of advancing care with the Auryon System improving the physician experience, and ultimately helping to change patients’ lives. Learn more ▶️ bit.ly/47aRiYV Risk information ▶️ bit.ly/3IOQLC2
“By 2045, we're going to have an epidemic.” Dr. @AnahitaDua As diabetes rates rise, below-the-knee peripheral artery disease is growing. bit.ly/47aRiYV AMBITION BTK is sponsored by @angiodynamics. Dr. Dua is co-principal investigator of the study. bit.ly/3IOQLC2
For those living with PAD, amputation should never feel like the only option. That’s why the Auryon System was designed to treat the full spectrum of lesions helping physicians restore blood flow and preserve limbs. ▶️ bit.ly/47aRiYV Risks ▶️ bit.ly/3IOQLC2
“This study is all about the patients.” – Dr. @AnahitaDua Learn more ▶️ bit.ly/464ZJTE #PADAwarenessMonth Risk information ▶️ bit.ly/3UFe4Rf The AMBITION BTK study is sponsored by @angiodynamics. Dr. Dua is a co-principal investigator of the study.
Making lifestyle changes can greatly reduce your risk of #PAD: • Quit smoking • Exercise daily • Manage blood pressure, cholesterol, and diabetes • Care for your feet with regular checks Let’s raise awareness and take action▶️ bit.ly/47aRiYV bit.ly/3IOQLC2
September is #PADAwarenessMonth – a time to shine light on Peripheral Artery Disease #TheAuryonSystem was purpose-built to help treat complex disease providing versatility for the full range of lesions they may encounter. ▶️ bit.ly/47aRiYV Risks bit.ly/3IOQLC2
Only a few more days to come see the Auryon team! Visit us at Booth 302. Learn more about the Auryon System ▶️ bit.ly/47aRiYV @AMPSymposium #AMP2025 #AngioDynamics #Auryon #TheAuryonSystem Risk Info: bit.ly/3IOQLC2
🎉Dr. Luis Leon will present late-breaking data on August 14 at #AMP2025, exploring POBA vs. DCB as adjunctive therapy following use of the #AuryonLaserSystem. Visit the #Auryon team at Booth 302. ▶️ bit.ly/47aRiYV @AMPSymposium Risk: bit.ly/3IOQLC2
We’re kicking off #AMP2025 with a live case! This is a great opportunity to learn how #TheAuryonSystem advances the treatment of peripheral arterial disease. Visit the #Auryon team at Booth 302. ▶️ bit.ly/47aRiYV @AMPSymposium Risk Info: bit.ly/3IOQLC2
We look forward to an event of engaging sessions, expert clinical and scientific perspectives, and meaningful insights. Visit the #Auryon team at Booth 302. ▶️ bit.ly/47aRiYV @AMPSymposium #AngioDynamics #TheAuryonSystem #AMP2025 Risk Info: bit.ly/3IOQLC2
Congratulations to Dr. @AnahitaDua and the team at @MassGeneralNews on successfully enrolling the first patient in the #AMBITIONBTK multicenter randomized controlled trial. ▶️ investors.angiodynamics.com/news-releases/… auryon-system.com/risk-informati…
Are you ready to share your bold ideas, cutting-edge research, and clinical innovation in #cardiovascularcare? The Cardiovascular Pitch is your chance to make a high-impact impression! 📅 Deadline: Sept. 15, 2025 ▶️ angiodynamics.com/improving-care… #CVSF2025 #AngioDynamics #MedTech
Kimberly Nelson, Senior Director, Global Marketing, shares what makes #CVSF so powerful: “Bringing together science, strategy, and heart—the Cardiovascular Scientific Forum is where real change begins.” 📍 Phoenix, AZ 📅 October 10–12, 2025 💡 Innovation. Research. Collaboration.
United States Trendy
- 1. National Guard 120K posts
- 2. Thanksgiving 435K posts
- 3. #InfoSecVPN N/A
- 4. Frank Ragnow 5,263 posts
- 5. D.C. 227K posts
- 6. Bayern 169K posts
- 7. Arsenal 302K posts
- 8. Mbappe 99.4K posts
- 9. Konate 7,964 posts
- 10. Patrick Morrisey 2,864 posts
- 11. Neuer 8,401 posts
- 12. Kimmich 5,900 posts
- 13. Merino 8,277 posts
- 14. #ARSBAY 5,073 posts
- 15. Denzel 4,479 posts
- 16. WV Governor 3,532 posts
- 17. Olympiacos 22.1K posts
- 18. Anthony Rendon N/A
- 19. Lennart Karl 6,898 posts
- 20. Vini 35K posts
Something went wrong.
Something went wrong.